Search
Now showing items 1-10 of 18
Fertility preservation in breast cancer patients
(Springer, 2022)
Breast cancer is the most common malignancy in
women as it currently represents 15.2% of all
new cancer cases in the United States with
268,600 estimated new cases in 2019 [1]. Under
45 years of age, the percentage of ...
Ovarian stimulation and PGT-A outcomes with random start letrozole protocol for fertility preservation in breast cancer patients
(Oxford University Press, 2022)
Study question
Data on random start letrozole ovarian stimulation (RSL) in breast cancer patients is scant. We studied RSL outcomes from a single-center with fertility preservation expertise.
Summary answer
RSL appears ...
Role of chemokines in early pregnancy loss
(Spandidos Publications, 2022)
The present study aimed to compare decidual protein levels and gene expression levels of chemokines between patients with early pregnancy loss and those with voluntary abortion. A total of 15 patients between 6 and 10 ...
Overall approach to fertility preservation and ındications for ovarian tissue harvesting and cryopreservation
(Elsevier, 2022)
The field of fertility preservation has significantly evolved in the last two decades. Embryo, oocyte, and ovarian tissue cryopreservation are the well-established options for women pursuing fertility preservation. Ovarian ...
Preoperative evaluation and preparation for ovarian tissue transplant surgery
(Elsevier, 2022)
Ovarian tissue cryopreservation is a fertility preservation method which is no longer experimental. The number of healthy babies born with this technique is approaching 200 worldwide. It is the only option for preserving ...
Comparison of random start controlled ovarian stimulation with kiandard start in letrozole gonadotropin cycles for fertility preservation in women with breast cancer
(Elsevier, 2023)
Random start controlled ovarian stimulation (RSCOH) was introduced as an option for women with cancer who do not have sufficient time for early follicular start ovarian stimulation protocols for fertility preservation. Our ...
Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer
(Elsevier, 2023)
The likelihood of post-chemotherapy (ChT) amenorrhea is still empirically determined. Breast cancer is the most prevalent malignancy among the women of reproductive age. Our aim was to determine the predictors of amenorrhea ...
Ovarian stimulation and oocyte cryopreservation in females with cancer
(Lippincott Williams & Wilkins, 2023)
Purpose of review: We reviewed the most recent developments including the safety and effectiveness data and success rates in individualized ovarian stimulation protocols for adult and postpubertal females with cancer. ...
Assessment of carotid artery intima-media thickness and lipid profile in term neonates born to smoking mothers
(Tehran University of Medical Sciences, 2021)
Background: It is well-known that cigarette smoke contains chemical substances, including nicotine and carbon monoxide, which
can have harmful effects on cardiovascular function.
Objectives: This study aimed to investigate ...
Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency
(Springer/Plenum Publishers, 2023)
Purpose To assess the feasibility and outcomes of oocyte cryopreservation with in vitro maturation (IVM) in post-pubertal girls undergoing fertility preservation (FP) for primary ovarian insufciency (POI) risk. Methods ...
